Mechanism of Non-Competitive Inhibition of the SARS-CoV-2 3CL Protease Dimerization: Therapeutic and Clinical Promise of the Lichen Secondary Metabolite Perlatolinic Acid
Heliyon(2024)
关键词
SARS-CoV-2 3CL protease inhibition,Perlatolinic acid antiviral activity,Lichen metabolites against COVID-19,3CL protease dimer interface,Broad-spectrum COVID-19 therapeutics
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要